Your browser doesn't support javascript.
loading
Recovery of plasma vascular endothelial growth factor concentrations during aflibercept loading phase and after the transition to bimonthly treatment for neovascular age-related macular degeneration.
Roald, Anca B; Aass, Hans C D; Moe, Morten C.
Affiliation
  • Roald AB; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
  • Aass HC; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
  • Moe MC; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway Faculty of Medicine, University of Oslo, Oslo, Norway.
Br J Ophthalmol ; 99(12): 1610-3, 2015 Dec.
Article in En | MEDLINE | ID: mdl-25966740
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Angiogenesis Inhibitors / Receptors, Vascular Endothelial Growth Factor / Vascular Endothelial Growth Factor A / Wet Macular Degeneration Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Ophthalmol Year: 2015 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Angiogenesis Inhibitors / Receptors, Vascular Endothelial Growth Factor / Vascular Endothelial Growth Factor A / Wet Macular Degeneration Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Ophthalmol Year: 2015 Document type: Article Affiliation country: Country of publication: